Vanda Pharmaceuticals
VNDA
#7861
Rank
ยฃ0.23 B
Marketcap
ยฃ4.04
Share price
3.65%
Change (1 day)
7.92%
Change (1 year)

Revenue for Vanda Pharmaceuticals (VNDA)

Revenue in 2025 (TTM): ยฃ0.16 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ0.15 Billion. In 2024 the company made a revenue of ยฃ0.15 Billion an increase over the revenue in the year 2023 that were of ยฃ0.15 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Vanda Pharmaceuticals from 2009 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ0.16 B1.81%
2024 ยฃ0.15 B4.75%
2023 ยฃ0.15 B-28.09%
2022 ยฃ0.21 B5.64%
2021 ยฃ0.19 B9.33%
2020 ยฃ0.18 B5.09%
2019 ยฃ0.17 B13.88%
2018 ยฃ0.15 B24.55%
2017 ยฃ0.12 B3.22%
2016 ยฃ0.11 B59.53%
2015 ยฃ74.17 M130.26%
2014 ยฃ32.21 M56.85%
2013 ยฃ20.53 M1.44%
2012 ยฃ20.24 M0.64%
2011 ยฃ20.11 M-13.03%
2010 ยฃ23.13 M723.09%
2009 ยฃ2.81 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novartis
NVS
ยฃ42.28 B 26,481.29%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
ยฃ44.56 B 27,918.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ69.11 B 43,351.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ36.02 B 22,549.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ47.09 B 29,505.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ48.18 B 30,188.96%๐Ÿ‡บ๐Ÿ‡ธ USA